| Joseph Stephen Yusin, MD | |
|
650 E Indian School Rd, Phoenix, AZ 85012-1839 | |
| (602) 277-5551 | |
| Not Available |
| Full Name | Joseph Stephen Yusin |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology |
| Location | 650 E Indian School Rd, Phoenix, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912091927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 30973 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Stephen Yusin, MD 2925 E Rose Ln, Phoenix, AZ 85016-2100 Ph: (602) 277-5551 | Joseph Stephen Yusin, MD 650 E Indian School Rd, Phoenix, AZ 85012-1839 Ph: (602) 277-5551 |
News Archive
University of Alberta researchers have discovered a mechanism that may make cancer cells more susceptible to treatment. The research team found that the protein RYBP prevents DNA repair in cancer cells, including breast cancer.
As the U.S. wrestles with rising health expenses, one group of patients stands out for government-paid care that is both ultra-costly and plagued with problems.
DaVita Kidney Care, a division of DaVita Inc., a leading provider of kidney care services in the United States, today announced results of the first performance year in the Centers for Medicare and Medicaid Services Comprehensive ESRD Care Model as an ESRD Seamless Care Organization.
The Executive Order President Obama issued Monday directing the U.S. Food and Drug Administration to take action to reduce prescription drug shortages is a commendable first step, but the White House could strengthen its directive and address the full scope of the problem by ordering mandatory reporting by manufacturers, which The Endocrine Society calls for in its Position Statement on drug shortages.
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application for ABILIFY (aripiprazole) for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder, with or without psychotic features in pediatric patients (10 to 17 years old).
› Verified 8 days ago
Fadia K Habib-khazen, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4901 N 44th St Ste 103, Phoenix, AZ 85018 Phone: 602-954-0405 Fax: 602-954-0485 | |
Mark Samuel Schubert, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 W Clarendon Ave, Ste 120, Phoenix, AZ 85013 Phone: 602-277-3337 Fax: 602-277-3330 | |
Praveena R Kothur, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4901 N 44th St Ste 103, Phoenix, AZ 85018 Phone: 602-954-0405 Fax: 602-954-0485 | |
Dr. Christopher E. Couch, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 300 W Clarendon Ave, Suite 120, Phoenix, AZ 85013 Phone: 602-277-3337 Fax: 602-277-3330 | |
Dr. Allan M Wachter, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 12020 S Warner Elliot Loop, Suite 124, Phoenix, AZ 85044 Phone: 480-785-8000 Fax: 480-705-8129 | |
Dr. Stephen N Finberg, D.O. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 6970 E Chauncey Ln Ste 100, Phoenix, AZ 85054 Phone: 602-788-7211 Fax: 602-788-1890 | |
Thomas Mirzai, D.O. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3815 E Bell Rd, 4400, Phoenix, AZ 85032 Phone: 602-788-7211 Fax: 602-788-1890 |